Overview
For more information see http://ed-media.mc.duke.edu/BMT.nsf
Current Appointments & Affiliations
Donald D. and Elizabeth G. Cooke Cancer Distinguished Research Professor
·
2002 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Professor of Medicine
·
2001 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Professor in Immunology
·
2001 - Present
Integrative Immunobiology,
Basic Science Departments
Professor in Pathology
·
2011 - Present
Pathology,
Clinical Science Departments
Research Professor of Global Health
·
2013 - Present
Duke Global Health Institute,
University Institutes and Centers
Member of the Duke Cancer Institute
·
1996 - Present
Duke Cancer Institute,
Institutes and Centers
Chief, Division of Cell Therapy in the Department of Medicine
·
2004 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Affiliate of the Duke Regeneration Center
·
2021 - Present
Duke Regeneration Center,
Basic Science Departments
Recent Publications
Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation period.
Journal Article Blood Adv · May 13, 2025 Gut dysbiosis is linked to mortality and the development of graft-versus-host disease after hematopoietic stem cell transplantation (HSCT), but the impact of cutaneous dysbiosis remains unexplored. We performed a pilot observational study, obtained retroau ... Full text Link to item CiteFood insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomes.
Journal Article Bone Marrow Transplant · April 12, 2025 Food insecurity (FI), defined as the lack of continuous access to adequate food, affects 17-55% of cancer patients. Effects may be exacerbated in hematopoietic stem cell transplant (HSCT) patients, who face nutritional challenges due to treatment side effe ... Full text Link to item CiteImmersive Virtual Reality for Enabling Patient Experience and Enrollment in Oncology Clinical Trials: A Feasibility Study.
Journal Article Cancers (Basel) · March 29, 2025 Background/Objectives: Informed consent is a crucial part of the clinical trial enrollment process in which patients are asked to understand and provide approval for medical interventions. Consent forms can be complex and hinder patient comprehension, high ... Full text Link to item CiteRecent Grants
Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Allergy and Infectious Diseases · 2019 - 2029Improving access to cancer care for children in Tanzania: Designing a health-systems intervention
ResearchCo-Mentor · Awarded by Fogarty International Center · 2022 - 2027View All Grants
Education, Training & Certifications
Yale University ·
1981
M.D.